Logo image of PLMJ

PLUM ACQUISITION CORP III (PLMJ) Stock Fundamental Analysis

NASDAQ:PLMJ - Nasdaq - KYG632901115 - Common Stock - Currency: USD

11  -0.9 (-7.56%)

After market: 10.96 -0.04 (-0.36%)

Fundamental Rating

1

Taking everything into account, PLMJ scores 1 out of 10 in our fundamental rating. PLMJ was compared to 0 industry peers in the Unkown industry. PLMJ may be in some trouble as it scores bad on both profitability and health. PLMJ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PLMJ was profitable.
PLMJ had a negative operating cash flow in the past year.
PLMJ Yearly Net Income VS EBIT VS OCF VS FCFPLMJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

Industry RankSector Rank
ROA 6.29%
ROE 7.28%
ROIC N/A
ROA(3y)3.31%
ROA(5y)N/A
ROE(3y)3.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PLMJ Yearly ROA, ROE, ROICPLMJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 4 6

1.3 Margins

PLMJ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PLMJ Yearly Profit, Operating, Gross MarginsPLMJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, PLMJ has less shares outstanding
PLMJ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PLMJ Yearly Shares OutstandingPLMJ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
PLMJ Yearly Total Debt VS Total AssetsPLMJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 18.87 indicates that PLMJ is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.05 indicates that PLMJ is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 18.87
ROIC/WACCN/A
WACCN/A
PLMJ Yearly LT Debt VS Equity VS FCFPLMJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

PLMJ has a Current Ratio of 0.07. This is a bad value and indicates that PLMJ is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.07 indicates that PLMJ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
PLMJ Yearly Current Assets VS Current LiabilitesPLMJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

1

3. Growth

3.1 Past

PLMJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.11%, which is quite impressive.
EPS 1Y (TTM)37.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-255.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PLMJ Yearly Revenue VS EstimatesPLMJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
PLMJ Yearly EPS VS EstimatesPLMJ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 366.67, the valuation of PLMJ can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.63, PLMJ is valued quite expensively.
Industry RankSector Rank
PE 366.67
Fwd PE N/A
PLMJ Price Earnings VS Forward Price EarningsPLMJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PLMJ Per share dataPLMJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PLMJ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLUM ACQUISITION CORP III

NASDAQ:PLMJ (1/27/2025, 8:20:26 PM)

After market: 10.96 -0.04 (-0.36%)

11

-0.9 (-7.56%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners69.58%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap112.31M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 366.67
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.08
P/tB 5.08
EV/EBITDA N/A
EPS(TTM)0.03
EY0.27%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0
BVpS2.16
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.29%
ROE 7.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.31%
ROA(5y)N/A
ROE(3y)3.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 18.87
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-255.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.5%
OCF growth 3YN/A
OCF growth 5YN/A